Femara 2.5 mg, 30 tablets (Letrozole 2.5 mg per tablet) by Novartis.
Indications: Hormone receptor-positive breast cancer in post-menopausal women (adjuvant, extended adjuvant and advanced treatment).
Administration: Oral: 2.5 mg once daily.
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Novartis |
| Active ingredient | Letrozole 2.5 mg per tablet — non-steroidal aromatase inhibitor. |
| Strength & pack | 30 film-coated tablets. |
| Form | Film-coated tablets |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |